Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$150M |
| 2 |
Johnson Controls International
JCI
|
+$145M |
| 3 |
ExxonMobil
XOM
|
+$135M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$437M |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$146M |
| 3 |
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
|
+$108M |
| 4 |
Danaher
DHR
|
+$103M |
| 5 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$84.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.39% |
| 2 | Healthcare | 14.53% |
| 3 | Financials | 14.37% |
| 4 | Industrials | 10.28% |
| 5 | Consumer Discretionary | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$379B
| $1.37B | 0.69% |
32,338,651
+973,950
| +3% | +$42.7M |
2013 Q2
13 quarters
|
|
27
Philip Morris
PM
$314B
| $1.29B | 0.65% |
13,335,905
+524,728
| +4% | +$52.6M |
2013 Q2
13 quarters
|
|
28
IBM
IBM
$214B
| $1.27B | 0.64% |
8,394,425
+336,229
| +4% | +$51M |
2013 Q2
13 quarters
|
|
29
Walt Disney
DIS
$187B
| $1.25B | 0.63% |
13,446,049
+541,941
| +4% | +$51.9M |
2013 Q2
13 quarters
|
|
30
Citigroup
C
$217B
| $1.18B | 0.59% |
25,043,810
+828,978
| +3% | +$37.7M |
2013 Q2
13 quarters
|
|
31
Amgen
AMGN
$224B
| $1.1B | 0.56% |
6,625,328
+156,926
| +2% | +$26.5M |
2013 Q2
13 quarters
|
|
32
UnitedHealth
UNH
$340B
| $1.1B | 0.55% |
7,878,851
+250,980
| +3% | +$35.2M |
2013 Q2
13 quarters
|
|
33
Medtronic
MDT
$113B
| $1.03B | 0.52% |
11,980,641
+334,514
| +3% | +$29.1M |
2013 Q2
13 quarters
|
|
34
Altria Group
MO
$120B
| $1.03B | 0.52% |
16,269,606
+329,818
| +2% | +$21.9M |
2013 Q2
13 quarters
|
|
35
Oracle
ORCL
$429B
| $1.02B | 0.51% |
26,002,846
+143,474
| +0.6% | +$5.85M |
2013 Q2
13 quarters
|
|
36
Gilead Sciences
GILD
$187B
| $1B | 0.51% |
12,708,690
+466,974
| +4% | +$37.9M |
2013 Q2
13 quarters
|
|
37
Qualcomm
QCOM
$187B
| $1B | 0.5% |
14,634,512
+858,063
| +6% | +$52.2M |
2013 Q2
13 quarters
|
|
38
3M
MMM
$82.5B
| $986M | 0.5% |
6,699,134
+269,323
| +4% | +$40.2M |
2013 Q2
13 quarters
|
|
39
Walmart Inc
WMT
$883B
| $979M | 0.49% |
40,774,494
+1,411,254
| +4% | +$34.2M |
2013 Q2
13 quarters
|
|
40
SLB Ltd
SLB
$72.6B
| $939M | 0.47% |
11,953,388
+537,445
| +5% | +$42.7M |
2013 Q2
13 quarters
|
|
41
Mastercard
MA
$516B
| $917M | 0.46% |
9,023,180
+399,307
| +5% | +$38.3M |
2013 Q2
13 quarters
|
|
42
McDonald's
MCD
$166B
| $896M | 0.45% |
7,774,469
+230,905
| +3% | +$27.4M |
2013 Q2
13 quarters
|
|
43
AbbVie
ABBV
$489B
| $845M | 0.43% |
13,414,986
+556,563
| +4% | +$36M |
2013 Q2
13 quarters
|
|
44
Honeywell
HON
$65.8B
| $787M | 0.4% |
7,525,681
+327,789
| +5% | +$34.3M |
2013 Q2
13 quarters
|
|
45
CVS Health
CVS
$110B
| $780M | 0.39% |
8,776,165
+192,933
| +2% | +$18.2M |
2013 Q2
13 quarters
|
|
46
Starbucks
SBUX
$103B
| $766M | 0.39% |
14,162,473
+685,290
| +5% | +$38.3M |
2013 Q2
13 quarters
|
|
|
AGN
47
DELISTED
Allergan plc
AGN
| $761M | 0.38% |
3,307,937
+115,593
| +4% | +$28.2M |
2015 Q3
4 quarters
|
|
48
Bristol-Myers Squibb
BMY
$121B
| $759M | 0.38% |
14,090,181
+650,041
| +5% | +$41.8M |
2013 Q2
13 quarters
|
|
49
Union Pacific
UNP
$165B
| $748M | 0.38% |
7,683,110
+329,268
| +4% | +$30.8M |
2013 Q2
13 quarters
|
|
50
Accenture
ACN
$128B
| $723M | 0.36% |
5,925,731
+308,091
| +5% | +$35.1M |
2013 Q2
13 quarters
|
|
Similar funds
Geode Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Geode Capital Management held 4,151 positions worth $199B, up 8% from $184B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management deployed $6.98B of net new capital in Q3 2016, opening 137 new positions and adding to 3,050 existing holdings. Its largest new stake was Fortive: 4,005,895 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Danaher, an estimated $103M trimmed.
- Geode Capital Management's largest Q3 2016 buy was Fortive: 4,005,895 shares worth $128M.
- Geode Capital Management added most to Johnson & Johnson in Q3 2016, an estimated $150M increase.
- Geode Capital Management's biggest Q3 2016 reduction was Danaher, cutting an estimated $103M.
- Geode Capital Management fully exited EMC CORPORATION in Q3 2016, selling an estimated $437M.
- Geode Capital Management's ten largest holdings make up 15% of its $199B portfolio in Q3 2016.
- Geode Capital Management opened 137 new positions and closed 123 in Q3 2016.
- Geode Capital Management's portfolio value rose 8% quarter-over-quarter to $199B.
Based on Geode Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.